Luke Mountjoy

Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome

N. Jewel Samadder, Douglas L. Riegert‐Johnson, Deborah J. Rhodes et al. · JAMA Oncology · 2020 · 294 citations · Full text

Life Sciences, Genetics, Oncology +17

Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia

Claire Roddie, Karamjeet Sandhu, Eleni Tholouli et al. · New England Journal of Medicine · 2024 · 196 citations · Full text

Medicine, Hematology, Oncology +15

Germline Cancer Susceptibility Gene Testing in Unselected Patients With Colorectal Adenocarcinoma: A Multicenter Prospective Study

Pedro Luiz Serrano Usón, Douglas L. Riegert‐Johnson, John B. Kisiel et al. · Clinical Gastroenterology and Hepatology · 2021 · 77 citations · Full text

Medicine, Genetics, Oncology +17

Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL

Gregory W. Roloff, Ibrahim Aldoss, Noam E. Kopmar et al. · Journal of Clinical Oncology · 2024 · 32 citations · Full text

Life Sciences, Hematology, Immunology +13

A Phase 1 Study of NKX101, a Chimeric Antigen Receptor Natural Killer (CAR-NK) Cell Therapy, with Fludarabine and Cytarabine in Patients with Acute Myeloid Leukemia

Craig S. Sauter, Gautam Borthakur, Luke Mountjoy et al. · Blood · 2023 · 28 citations

Medicine, Oncology, Pharmacology +17